Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pellat

Showing results (91-100 of 320) with videos related to

Pageof 32
Sort By:
European Cytokine Network|September 8, 2007
Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cellsMadeleine Collette, Géraldine Descamps, Catherine Pellat-Deceunynck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1997
The phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effectsO Moreaud, N Fournet, J L Roulin, et al.
Acta Neuropathologica|December 30, 1975
Primary rhabdomyosarcoma of the central nervous systemB Pasquier, P Couderc, D Pasquier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1996
Working memory in medicated patients with Parkinson's disease: the central executive seems to workN Fournet, O Moreaud, J L Roulin, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of inhibitors of ADP-ribosylation on macrophage activationC Le Page, C Pellat-Deceunynck, J C Drapier, et al.
International Immunology|July 20, 2005
Allogeneic T lymphocytes as a source of peptide-dependent T cells specific for myeloma cellsAlexandrine Geffroy-Luseau, Agnès Moreau-Aubry, Régis Bataille, et al.
Journal of Hematology & Oncology|April 23, 2015
Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosisSophie Bustany, Julie Cahu, Géraldine Descamps, et al.
Blood|February 7, 1998
A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndromeM E Martin, S Fargion, P Brissot, et al.
ESMO Open|November 18, 2022
Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?M S Rémond, A Pellat, C Brezault, et al.
Frontiers in Oncology|March 22, 2019
Targeting Oxidative Stress With Auranofin or Prima-1<sup>Met</sup> to Circumvent p53 or Bax/Bak Deficiency in Myeloma CellsBenoit Tessoulin, Geraldine Descamps, Christelle Dousset, et al.
Pageof 32

Showing results (91-100 of 320) with videos related to

Sort By:
Pageof 32
European Cytokine Network|September 8, 2007
Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cellsMadeleine Collette, Géraldine Descamps, Catherine Pellat-Deceunynck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1997
The phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effectsO Moreaud, N Fournet, J L Roulin, et al.
Acta Neuropathologica|December 30, 1975
Primary rhabdomyosarcoma of the central nervous systemB Pasquier, P Couderc, D Pasquier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1996
Working memory in medicated patients with Parkinson's disease: the central executive seems to workN Fournet, O Moreaud, J L Roulin, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of inhibitors of ADP-ribosylation on macrophage activationC Le Page, C Pellat-Deceunynck, J C Drapier, et al.
International Immunology|July 20, 2005
Allogeneic T lymphocytes as a source of peptide-dependent T cells specific for myeloma cellsAlexandrine Geffroy-Luseau, Agnès Moreau-Aubry, Régis Bataille, et al.
Journal of Hematology & Oncology|April 23, 2015
Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosisSophie Bustany, Julie Cahu, Géraldine Descamps, et al.
Blood|February 7, 1998
A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndromeM E Martin, S Fargion, P Brissot, et al.
ESMO Open|November 18, 2022
Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?M S Rémond, A Pellat, C Brezault, et al.
Frontiers in Oncology|March 22, 2019
Targeting Oxidative Stress With Auranofin or Prima-1<sup>Met</sup> to Circumvent p53 or Bax/Bak Deficiency in Myeloma CellsBenoit Tessoulin, Geraldine Descamps, Christelle Dousset, et al.
Pageof 32